| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,016 |
825 |
$0.00 |
| 80061 |
Lipid panel |
263 |
263 |
$0.00 |
| 86703 |
|
86 |
85 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
13 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
14 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12 |
12 |
$0.00 |
| 86480 |
|
12 |
12 |
$0.00 |
| 91300 |
|
13 |
13 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
594 |
569 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
89 |
86 |
$0.00 |
| 82728 |
|
12 |
12 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
235 |
221 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
27 |
27 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
663 |
629 |
$0.00 |
| 86593 |
|
13 |
12 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,438 |
1,313 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
430 |
430 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
86 |
86 |
$0.00 |
| 85027 |
|
60 |
58 |
$0.00 |
| 87340 |
|
27 |
27 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$0.00 |
| 86780 |
|
51 |
51 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28 |
27 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
28 |
28 |
$0.00 |
| 86706 |
|
29 |
29 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
13 |
13 |
$0.00 |